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http://dx.doi.org/10.1016/j.kjms.201Abstract Adenoid cystic carcinoma (ACC) is characterized by intensive local invasion and
high incidence of distant metastases. Conventional chemotherapy for ACC produces a poor
result. We aimed to evaluate the effect of apple polyphenols (APs), a novel nutraceutical
agent, on the proliferation and apoptosis levels in a metastatic oral ACC cell line. A metastatic
ACC (ACC-M) cell line and control cells (MRC-5 cells derived from normal lung tissue) were
treated with APs at different concentrations. MTT assay was used to determine the in vitro
cytotoxicity. The cell cycle distribution and apoptosis levels were measured by flow cytometry.
To evaluate the mechanism of APs, vascular endothelial growth factor receptor-2 (VEGFR-2)
and caspase-3 messenger ribonucleic acid (mRNA) and protein levels were evaluated by
reverse transcription-polymerase chain reaction and Western blots, respectively. After cells
were cultured for 24 hours or 48 hours, the critical concentration of cytotoxicity of APs in
MRC-5 cells was found to be 250 mg/mL. In contrast, in the concentration range of 100
e250 mg/mL, the cytotoxicity of APs in ACC-M cells was time- and dose-dependent: ACC-M cell
proliferation declined at 100 mg/mL when cultured for 48 hours, whereas growth was not inhib-
ited at the concentrations of APs below 200 mg/mL when cultured for 24 hours. In selected
time and dose patterns (ACC-M cells cultured at the concentrations of 150 and 250 mg/mL
for 48 hours), the flow cytometry performance showed that apoptosis and necrosis occurred
in APs-treated ACC-M cells. Also, in these patterns, VEGFR-2 mRNA and protein levels
decreased whereas the levels of caspase-3 increased. In summary, APs could inhibitt of Oral and Maxillofacial Surgery, Guanghua School of Stomatology, Sun Yat-sen University,
ce, China.
.edu.cn (Q. Tao).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
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240 C.-Q. Zheng et al.proliferation and induce apoptosis in ACC-M cells in vitro. These effects may be related to the
downregulation of VEGFR-2 expression and the activation of caspase-3 expression.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Oral adenoid cystic carcinoma (ACC) is the second most
commonmalignant neoplasm of the salivary glands [1] and it
is characterized by a high rate of recurrence and early
development of hematogenous metastasis [2,3]. Oral ACC
has an aggressive clinical course andhas a tendency to invade
nerves, resulting in pain, numbness, and/or paralysis.
Currently, the most effective treatment for ACC is a combi-
nation therapy involving surgery, postoperative radiation,
and chemotherapy [4]. Most deaths from salivary ACC occur
due to lung metastases that are resistant to chemotherapy.
Improved systemic therapies, novel cancer chemopreventive
agents, or nutraceutical agents are therefore necessary for
the treatment of patients with ACC.
Chemoprevention [5,6] aims to block, inhibit, or reverse
the development and progression of precancerous cells by
using noncytotoxic nutrients and/or pharmacologic agents
[7]. The validation and utilization of dietary components,
natural products, or their synthetic analogs as chemo-
preventive agents in the form of foods or nutraceutical
agents has become an important issue in health- and
cancer-related research [8]. Several lines of evidence
suggest that apples and apple products, mainly apple
polyphenols (APs), possess a wide range of biologic activi-
ties that may have beneficial effects against many diseases
[6]. Products extracted from apple skins have now been
shown to be effective in preventing tumor formation in
eight different types of cancer, including colorectal,
breast, prostate, and lung [9e13]. However, it is unclear
whether this kind of potential cancer chemopreventive
agent could be used in the treatment of oral ACC. In the
current study, we aimed to evaluate the effects of apple
polyphenols (APs) on the proliferation and apoptosis levels
in a metastatic oral ACC cell line. Furthermore, the
molecular mechanisms by which APs affect proliferation
and apoptosis were determined.Methods
The extraction of APs
APs were donated by Mr Xiansheng Qiao of the Zhengzhou
Fruit Research Institute, Chinese Academy of Agriculture
Sciences (Zhengzhou, China). The APs were extracted from
apple peels. Briefly, apple peels were placed in hot water,
the aqueous extract was crushed, and then the juice was
separated and filtered. After adsorption of the polyphenols
on adsorber resins and elimination of sugars, organic acids,
and minerals with water, the polyphenol fraction was
eluted with ethanol, concentrated, freeze-dried, and
stored under cool, dark, and dry conditions.Cell lines
The ACC-M cell line was established from a patient with
ACC and lung metastasis from Shanghai Ninth People’s
Hospital-affiliated Shanghai Jiaotong University School of
Medicine. MRC-5 cells were purchased from the American
Type Culture Collection (Manassas, VA, USA). The MRC-5
cell line was derived from normal lung tissue of a 14-
week-old male fetus, and this cell line was used as
a control for in vitro cytotoxicity testing. Both cell lines
were cultured in RPMI1640 medium (Invitrogen, Grand
Land, NY, USA) supplemented with 10% fetal bovine
serum (Biochrom, Berlin, Germany), 100 mM penicillin
and 100 mM streptomycin (Invitrogen, Grand Land, NY,
USA) and they were grown at 37C in a humidified
atmosphere of 5% CO2.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazoliumbromide (MTT) assay
ACC-M and MRC-5 cells (5 104 cells/mL) were seeded in 96-
well microtiter plates (Nunc, Roskilde, Denmark). The fresh
medium was removed by aspiration and new medium with
test substance was applied. APs were dissolved in RPMI1640
at the desired concentrations (0, 50, 100, 150, 200, 250, 300,
and 500 mg/mL). Cells treated for 24 hours and 48 hours were
selected. Experiments were performed in triplicate.
Flow cytometry
ACC-M cells (1  105) were seeded into six-well plates and
treated with 0, 150, and 250 mg/mL APs for 48 hours. The
morphologic changes of ACC-M cells were observed by
microscopy. Two sets of samples were used for flow
cytometry assay: one was selected to study the cell cycle
distribution and the other was set to determine the ratio of
apoptosis and necrosis. The cell cycle distribution assay was
detected by propidium iodide (Sigma, St.Louis, MO, USA)
staining, while the ratio of apoptosis and necrosis was
acquired by FITC-annexin V (Sigma, USA) staining. Each
experiment was repeated three times.
Semiquantitative reverse
transcriptionepolymerase chain reaction
After treatment with 0, 150, and 250 mg/mL APs for 48
hours, ACC-M cells were washed in phosphate-buffered
saline and harvested by mechanical scratching. Total
ribonucleic acid (RNA) was extracted from the cells using
TRIzol (Invitrogen, USA). The reverse transcription-
polymerase chain reactions (RTePCRs) were performed
using the Promega RTePCR kit (Promega, San Luis Obispo,








F Z forward primer sequence; R Z reverse primer sequence.
AP-induced apoptosis in ACC cells 241CA, USA) according to the manufacturer’s instructions.
Primer sequences are listed in Table 1. PCR cycling
conditions were as follows: initial denaturation at 95C for
2 minutes, subsequent amplification of 40 cycles at 95C
for 40 seconds, 56C for 20 seconds (VEGFR-2 and b-actin)
or 56C for 40 seconds (caspase-3), and 72C for 60
seconds with a final extension at 72C for 10 minutes. PCR
products were run on a 1.5% agarose gel and ethidium
bromide-stained bands were visualized and quantified
using UVP’s Gel Documentation System GDS8000 and
Gelworks LABWORK 4.0 Analysis Software (Syngene,
Frederick, MD, USA). Quantities of each PCR product were
normalized by dividing the average gray level of the signal
by that of the corresponding b-actin. All experiments
were carried out three times. For each experiment,
readings were taken in triplicate and the average and
standard deviations were calculated.
Western blotting analysis
The same cell pellets collected in RTePCR assay were used
for Western blotting. Briefly, cell pellets were lysed in cell
lysis buffer (Beyotime, China) for 30 minutes on ice. Then,
40 mg of protein lysate was separated by 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis, and
transferred onto 0.2-mm polyvinylidene difluoride
membrane (Bio-Rad, Hercules, CA, USA). After blocking in
a 5% bovine serum albumin solution for 1 hour, membranes
were incubated overnight at 4C with primary antibodies:
rabbit polyclonal anti-VEGFR-2, rabbit polyclonal
anticaspase-3, and rabbit monoclonal anti-b-actin (Abcam,
Cambridge, MA, USA). After washing three times with
Tween 20-Tris buffered saline, membranes were incubated
for 1 hour with horseradish peroxidase-conjugated
secondary antibody at room temperature. Signals were
detected with an enhanced chemiluminescence kit (Cell
Signaling Technology, Danvers, MA, USA) and captured on
X-ray film. The densitometry analysis was performed as for
the RT-PCR assay.
Statistical analysis
The data were analyzed by SPSS 13.0 software (SPSS Inc.,
Chicago, IL, USA). All data were presented as mean
values  standard deviation. The data were evaluated by
a one-way analysis of variance and Student t test for half-
maximal inhibitory concentration (IC50). Statistical signifi-
cance was set at p < 0.05.Results
APs decreased viability and inhibited growth of
ACC-M cells
ACC-M cells and control MRC-5 cells were exposed to APs at
various concentrations (0, 50, 100, 150, 200, 250, 300, and
500 mg/mL) for 24 hours or 48 hours, and cell viability was
determined by MTT assay. MRC-5 cells were used to detect
the critical in vitro cytotoxicity. As shown in Fig. 1A, top
panel, APs had no obvious toxic side effects on MRC-5 cells
until the concentration of APs reached 250 mg/mL. In
contrast, in the concentration range of 100e250 mg/mL, the
cytotoxicity of APs in ACC-M cells was time- and dose-
dependent: ACC-M cells proliferation began to decline at
100 mg/mL when cells were cultured for 48 hours, whereas
growth was not inhibited until the concentration of APs
reached 200 mg/mL when cells were cultured for 24 hours
(Fig. 1A, bottom panel). The IC50 values depended on time
of exposure. After 24 hours of treatment, the IC50 was
379  11 mg/mL whereas the IC50 was 276  9 mg/mL when
ACC-M cells were cultured for 48 hours.
AP treatment induced morphologic changes in
ACC-M cells
The morphologies of ACC-M cells treated with 150 and
250 mg/mL of APs for 48 hours were compared with those of
untreated cells by microscopy. Untreated ACC-M cells grew
adhesively and had polygonal morphology (Fig. 1B). In the
presence of APs, the morphology of ACC-M cells changed
from round to irregular, the cell face was rough, and the
nucleus was condensed. The effects were more pronounced
at the higher concentration of 250 mg/mL (Fig. 1B).
APs induced cell cycle arrest and apoptosis in ACC-
M cells
Flow cytometry was used to determine in which phase of
the cell cycle ACC-M cells were accumulated, and whether
apoptotic events occurred in response to APs exposure. In
contrast to untreated ACC-M cells, the cells treated with
APs were inhibited in G0/G1 phase in a dose-dependent
manner: When treated with 250 mg/mL for 48 hours, more
ACC-M cells (75.3%) were in G0/G1 than when treated with
of 150 mg/mL for the same time period (68.3%; Fig. 1C).
Compared with untreated cells, APs treatment increased
the numbers of cells that were apoptotic and necrotic
(Fig. 1D). Also, the ratios of apoptosis and necrosis in ACC-M
cells were in line with the results of the cell cycle: higher
concentration of APs lead to higher ratios of apoptosis and
necrosis.
The effect of APs on the expressions of VEGFR-2
and caspase-3
To evaluate the molecular mechanism by which APs exerted
cytotoxic effects on cultured ACC-M cells, we examined
mRNA and protein expressions of VEGFR-2 and caspase-3.
As shown in Fig. 2A, APs significantly inhibited the
Figure 1. Proliferation inhibition and apoptosis are induced in ACC-M cells by treatment with APs. (A) MRC-5 cells (a) and ACC-M
cells (b) are exposed to APs at various concentrations (0, 50, 100, 150, 200, 250, 300, and 500 mg/mL) for 24 hours or 48 hours and
cell viability was determined by using of MTT assay. *p < 0.05, **p < 0.01. (B) The morphologic changes of ACC-M cells cultured in
APs for 48 hours are observed by microscope. (C) The effects of APs on cell cycle distribution in ACC-M cells were determined by
flow cytometry. APs treatment leads to G0/G1 arrest and affects cell proliferation in ACC-M cells in a dose-dependent manner.
(D) The apoptotic and necrotic levels of ACC-M cells after AP exposure were detected by flow cytometry. The red points in Region 1
represent normal cells and those in Regions 2 and 3 are apoptotic and necrotic, respectively.
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Figure 2. The mechanisms by which APs play roles in ACC-M cells are studied on mRNA and protein levels by RTePCR and Western
blotting in triplicate. (A) The RTePCR results show that 150 and 250 mg/mL of APs significantly inhibit the expressions of VEGFR-2
but increase the expressions of caspase-3 in ACC-M cells compared to untreated cells. (B) The Western blotting results show the
same trends of VEGFR-2 and caspase-3 to the results of RTePCR on protein levels. *p < 0.05; **p < 0.01.
AP-induced apoptosis in ACC cells 243expression of VEGFR-2, while they increased the caspase-3
expression compared with untreated cells. The Western
blotting results were consistent with the results of RTePCR
assay (Fig. 2B).Discussion
Epidemiologic evidence points to the cancer preventive
potential of a diet rich in apples [6]. This effect has been
attributed to the presence of phytochemicals, especially
phenolic acids and flavonoids [14]. The phenolic constitu-
ents of apples, commonly known as APs, are distributed in
the peel, core, and pulp. APs include hydroxycinnamic
acids, dihydrochalcones, flavonols (quercetin glycosides),
catechins, and oligomeric procyanidins, as well as antho-
cyanins. APs inhibit growth and induce apoptosis in many
kinds of human tumor cells in vitro [9e12] and they have
shown beneficial effects in animal models [14e16].
Several studies indicated that APs were not toxic to
normal cells [17,18]. In our study, we evaluated the effect
of APs on MRC-5 cells, which are human embryonic lung
fibroblasts. MRC-5 cells were less sensitive to APs with no
toxicity when the concentration was less than 250 mg/mL.
In contrast, APs inhibited the growth of ACC-M cells in
a safe range of concentration. The lower limit was 200 mg/
mL when cells were treated for 24 hours, and the lowest
concentration was 100 mg/mL when cells were cultured for48 hours (Fig. 1A). These results were consistent with
previous reports that APs inhibited proliferation of colon
cancer, lung carcinoma, gastric adenocarcinoma, liver
cancer, melanoma, and mammary tumor cells [9e11].
Previous studies have demonstrated that APs cause
apoptosis in various cancer cell lines [9e11]. In this study, it
was shown that APs mediated apoptosis and necrosis of
ACC-M cells in vitro. After treatment with 150 or 250 mg/mL
of APs, cultured ACC-M cells showed morphologic changes
of typical apoptosis such as rough cell faces, condensed
nuclei, and presence of apoptotic bodies. Furthermore, the
flow cytometry results were in line with the microscopic
observations.
VEGF is a multifunctional angiogenic growth factor that
is a primary stimulant for the development and mainte-
nance of a vascular network in embryogenesis and the
vascularization of solid tumors. Two well-characterized
receptors for VEGF are selectively expressed on endothe-
lium. VEGFR-2 mediates endothelial cell mitogenesis and
permeability increase, whereas the role of VEGFR-1 has yet
to be clearly defined. Research indicates that VEGFR-2
plays a dominant role in mediating VEGF-induced vascular
permeability and tumor angiogenesis [19]. Based on data
from in vitro and in vivo studies, it appears that autocrine
and paracrine VEGF/VEGFR-2 signaling pathways coexist
[20e23]. Inhibition of the VEGF/VEGFR-2 autocrine
signaling pathway has a direct effect on the proliferation of
tumor cells [24,25] and the potential therapeutic effects of
244 C.-Q. Zheng et al.anti-VEGFR-2 antibody have been demonstrated [20,22,24].
Oral ACC is an angiogenesis-dependent tumor [22,26] with
high levels of expressions of VEGF and VEGFR-2 [26]. This
study found that VEGFR-2 expression in ACC-M cells was
downregulated on both mRNA and protein levels after AP
treatment. This suggests that by interrupting the VEGF/
VEGFR-2 signaling pathway, APs inhibit tumor cell growth.
Our data also showed that the levels of apoptosis in ACC-M
cells increased after APs exposure. Although this result is
consistent with the literature [27,28], the clear cascade has
not been studied. Apoptosis has many detected markers
including endonucleolytic cleavage of DNA, proteolytic
cleavage of nuclear and cellular proteins, and cell membrane
blotting. The comprehensive studied marker is the acquisi-
tion of apoptotic bodies through activation of the caspase
cascade [29,30]. Caspase-3 is an apoptosis mediator [16,28]
that serves as a convergence point for two different
caspase-dependent apoptosis pathways, the mitochondrial
pathway[16] andthedeath receptor (or tumornecrosis factor
receptor family) pathway [30]. Here, we showed that
caspase-3 expression in ACC-M cells was upregulated on both
mRNAandprotein levelsby treatedwithAPs.Thismayexplain
why the observed populations of apoptotic cells and necrotic
cells coexisted in ACC-M cells cultured in APs for 48 hours.
Paclitaxel is extracted from the bark of the Pacific yew
tree, and it has been widely used in cancer chemotherapy;
however, the therapeutic benefits of paclitaxel are
unstable; neurotoxicity could be observed if the dose
exceeds 200 mg/m2 in clinical use [31]. In this study, APs
are also natural plant extract, and the therapeutic window
of APs on carcinoma ACC-M cells is 100e250 mg/mL as
shown by MTT assay. In this safe range of concentration, the
specificity and sensitivity of APs both are satisfactory. It is
worth noting that the therapeutic window is quite narrow,
however. Whether APs can be used in clinical treatment
should depend on their effectiveness in xenograft studies.
Exploring this hypothesis will be the subject of further
research.
In conclusion, it is suggested that within a safe range of
concentration, APs inhibit proliferation and induce
apoptosis of ACC in vitro. Furthermore, the mechanisms by
which APs mediate the proliferation inhibition and the
apoptosis may be the downregulation of VEGFR-2 and the
activation of caspase-3, respectively.Acknowledgments
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